TransLite LLC of Sugar Land, TX at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair

TransLite LLC

345 Commerce Green Blvd., 77478 Sugar Land, TX
United States of America

Telephone +1 281 2403111
Fax +1 281 2403122
info@veinlite.com

This company is co-exhibitor of
Messe Düsseldorf North America

Hall map

MEDICA 2017 hall map (Hall 16): stand E40-14

Fairground map

MEDICA 2017 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.01  General Diagnostics

Our products

Product category: General Diagnostics

Veinlite LED+®

The newest adult model with optimum viewing area and highest contrast for vein imaging. The rechargeable Veinlite LED+ features 28 bright light emitting diodes (LEDs). The 22 bright orange and 6 deep red LEDs can be operated together or separately for maximum versatility and use on patients of all ages and skin tones. With this model there is no need to keep spare batteries in hand.

More Less

Product category: General Diagnostics

Veinlite PEDI®

Ideal for the NICU or newborn nursery, the Veinlite PEDI® is specifically designed for infants and neonates. Powered by one CR2 battery, this smallest and most compact version of the Veinlite LED product line has two switches operating 12 dual colored LEDs for variable light output. A snap-on neonate adapter facilitates through-the-body transillumination.

More Less

Product category: General Diagnostics

Veinlite LEDX®

Veinlite LEDX® is our portable transilluminator designed specifically for sclerotherapy and phlebectomy. Featuring a wider opening, a larger viewing area and 32 LEDs, the LEDX model has a deeper focus and is the ideal model for use on obese patients. With 24 orange and 8 red LEDs, this rechargeable unit also provides the highest contrast imaging for sclerotherapy treatments.

More Less

Product category: General Diagnostics

Veinlite LED Disposable Plastic Covers

  • Single pack contains 50 Veinlite LED disposable plastic covers.
  • 10 pack contains 500 Veinlite LED disposable plastic covers.

More Less

About us

Company details

OUR MISSION
To design innovative medical products that help mankind
Produce highest quality products at affordable prices
Provide excellent service and support to our customers
WHO WE ARE
TransLite LLC is a small high tech company comprising dedicated people who design, manufacture and sell medical devices that can help reduce the pain and trauma to patients during venous access and treatment of varicose veins.

IN THE BEGINING
TransLite LLC was started in 1992 to commercialize an innovative product called the Nevoscope for skin cancer detection. The Nevoscope device was designed by Dr. Atam Dhawan and used an innovative technique called side-transillumination for making a small area of the skin translucent. A patent was issued on the Nevoscope design to Dr. Dhawan and was assigned to Mr. Nizar Mullani for commercialization.

A new Nevoscope was designed by Mr. Mullani to incorporate cross-polarized surface imaging of the skin together with side-transillumination for skin cancer detection. This new device was used in a clinical study funded by the NIH to study the use of transillumination for skin cancer detection. The study was carried out at M D Anderson Melanoma Center under the direction of Dr. Duvic. Ms. Claire Terry was hired to oversee the image and data acquisition for this study. Over 250 skin lesions were imaged using the new Nevoscope. Five different modalities of imaging skin cancer were obtained for each lesion including contact and non-contact imaging with cross-polarized imaging and transillumiination.

Preliminary results from this study were presented at the American Academy of Dermatology Annual conference in 1998 by the researchers from M D Anderson Cancer Center. These results showed that cross-polarized imaging was a simple way of imaging superficial structures in the skin lesion while transillumination showed the deeper structures better. Moreover, imaging the skin lesion with contact glass plate reduced the “blush” caused by increased blood volume in a skin lesion. This was observed with both cross-polarized imaging and transillumination imaging. The effect was stronger for transillumination imaging.

CREATION OF THE DERMLITE
Cross polarized imaging of skin lesion was found to be very effective and easy way to image early skin cancer without the use of contact glass plate and oil as was used in the Dermatoscope in those days. In 2000, Mr. Mullani built a prototype of a small white LED based cross-polarized device called the DermLite for imaging skin lesions. This was demonstrated at the Annual Academy of Dermatology meeting in 2000 and a partnership was formed between Mr. Mullani, Mr. John Bottjer and Mr. Thorsten Trotzenberg to commercialize the DermLite for skin cancer detection. The newly formed company was called 3Gen and its first product called the DL 100 was introduced in 2001 at the AAD meeting. Today, over 50% of the dermatologists use DermLite products to screen for skin cancer and non-contact imaging with polarized light has become the main mode of skin cancer imaging for clinical screening.

More Less